Published in J Cardiovasc Transl Res on August 28, 2012
Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair (2013) 0.99
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch (2014) 0.98
The role of ubiquitin ligases in cardiac disease. J Mol Cell Cardiol (2013) 0.88
A TRP to cardiac fibroblast differentiation. Channels (Austin) (2013) 0.81
Using systems biology approaches to understand cardiac inflammation and extracellular matrix remodeling in the setting of myocardial infarction. Wiley Interdiscip Rev Syst Biol Med (2014) 0.80
Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium. Congest Heart Fail (2013) 0.80
Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int (2015) 0.77
Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice. Am J Transl Res (2016) 0.76
Visualization of network target crosstalk optimizes drug synergism in myocardial ischemia. PLoS One (2014) 0.75
Effect of Phosphatase and Tensin Homologue on Chromosome 10 on Angiotensin II-Mediated Proliferation, Collagen Synthesis, and Akt/P27 Signaling in Neonatal Rat Cardiac Fibroblasts. Biomed Res Int (2016) 0.75
Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction. J Am Heart Assoc (2014) 0.75
Association of retinoic acid receptors with extracellular matrix accumulation in rats with renal interstitial fibrosis disease. Int J Mol Sci (2012) 0.75
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps. Trends Pharmacol Sci (2017) 0.75
Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling. Adv Healthc Mater (2017) 0.75
Optimal Environmental Stiffness for Stem Cell Mediated Ischemic Myocardium Repair. Methods Mol Biol (2017) 0.75
Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med (2000) 5.05
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev (2007) 4.69
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest (2001) 4.63
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res (2007) 4.53
Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther (2009) 4.21
CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res (2005) 4.14
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med (2007) 3.98
A simplified laminin nomenclature. Matrix Biol (2005) 3.81
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell (2003) 3.68
The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol (1998) 3.65
Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol (2008) 3.62
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol (2010) 3.29
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem (2001) 3.28
Hyaluronan fragments: an information-rich system. Eur J Cell Biol (2006) 3.26
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol (2001) 3.22
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
Endogenous inhibitors of angiogenesis. Cancer Res (2005) 2.88
The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol (2009) 2.80
Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med (2008) 2.68
The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest (2001) 2.55
Osteopontin expression is required for myofibroblast differentiation. Circ Res (2007) 2.33
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res (2004) 2.31
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol (2005) 2.23
Infarct scar: a dynamic tissue. Cardiovasc Res (2000) 2.21
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol (2000) 2.21
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest (2009) 2.10
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation (2005) 2.09
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol (2007) 1.89
CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res (1999) 1.82
The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing. J Biol Chem (2002) 1.81
Structures of thrombospondins. Cell Mol Life Sci (2008) 1.74
The extracellular matrix: at the center of it all. J Mol Cell Cardiol (2009) 1.64
Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med (2008) 1.62
Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension (2005) 1.57
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res (2001) 1.56
Type IV collagen-derived angiogenesis inhibitors. Microvasc Res (2007) 1.51
Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol (2005) 1.46
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res (1991) 1.43
Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics (2010) 1.42
Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc Ther (2010) 1.39
Periostin family of proteins: therapeutic targets for heart disease. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.35
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol (2002) 1.31
Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J Mol Cell Cardiol (2009) 1.31
Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated. J Cell Biochem (2005) 1.30
Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res (2011) 1.28
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol (2010) 1.27
Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol (2009) 1.27
Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest (1996) 1.27
Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor. Am J Physiol Heart Circ Physiol (2007) 1.27
Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol (1998) 1.23
Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest (2001) 1.22
The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4. J Leukoc Biol (2007) 1.16
Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation (2004) 1.13
Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo. Mol Cell Biol (2009) 1.13
Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction. Circ Res (2011) 1.12
Matricellular proteins: an overview. J Cell Commun Signal (2009) 1.11
Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci (2001) 1.10
Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett (2005) 1.10
Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging. Microsc Microanal (2011) 1.09
Myofibroblasts in the infarct area: concepts and challenges. Microsc Microanal (2012) 1.08
Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2010) 1.08
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol (2006) 1.07
Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res (2002) 1.07
Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation (2011) 1.05
Non-fibrillar collagens: key mediators of post-infarction cardiac remodeling? J Mol Cell Cardiol (2009) 1.02
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2010) 1.01
Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell Tissue Res (2008) 1.00
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci (2012) 0.98
Matricryptins derived from collagens and proteoglycans. Front Biosci (Landmark Ed) (2011) 0.98
In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics. J Proteome Res (2010) 0.95
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One (2012) 0.94
Characterization of intramuscular collagen in mammalian left ventricle. Basic Res Cardiol (1983) 0.91
Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model. Circ J (2009) 0.91
Matricellular signaling molecule CCN1 attenuates experimental autoimmune myocarditis by acting as a novel immune cell migration modulator. Circulation (2010) 0.91
Reactive oxygen species expose cryptic epitopes associated with autoimmune goodpasture syndrome. J Biol Chem (2000) 0.91
SPARC mediates early extracellular matrix remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 0.90
Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol (2004) 0.89
Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. Cardiovasc Pathol (2003) 0.87
Sequential changes in laminin and type IV collagen in the infarct zone--immunohistochemical study in rat myocardial infarction. Jpn Circ J (1996) 0.84
Impaired angiogenic response in the corneas of mice lacking osteopontin. Invest Ophthalmol Vis Sci (2009) 0.84
Increased levels of laminin and collagen type VI may reflect early remodelling in patients with acute myocardial infarction. Acta Cardiol (2009) 0.83
Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs. Mol Cell Biochem (2008) 0.82
DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov (2012) 0.81
[Periostin function in the periodontal ligament and the periosteum]. Clin Calcium (2007) 0.81
Quantitative analysis of tenascin in chordae tendineae of human left ventricular papillary muscle with aging. Ann Anat (2001) 0.80
Plasma osteopontin levels in prediction of prognosis in acute myocardial infarction. Acta Cardiol (2011) 0.80
Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction. J Pharmacol Sci (2005) 0.79
Expression of the alpha 1 and alpha 2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol (1998) 0.78
Macrophage roles following myocardial infarction. Int J Cardiol (2008) 2.14
Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res (2012) 1.94
Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging. Circ Cardiovasc Genet (2011) 1.73
Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol (2012) 1.69
Effects of early and late chronic pressure overload on extracellular matrix remodeling. Hypertens Res (2008) 1.47
Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction. Proteomics (2010) 1.42
Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. Physiology (Bethesda) (2013) 1.41
Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol (2005) 1.37
Extracellular matrix roles during cardiac repair. Life Sci (2010) 1.32
Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences. J Mol Cell Cardiol (2009) 1.31
Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice. Cardiovasc Res (2012) 1.25
The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol (2012) 1.22
Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest (2011) 1.21
Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther (2013) 1.21
Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms. Exp Gerontol (2007) 1.20
Long-lived ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci (2009) 1.18
Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation (2005) 1.15
CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 1.13
Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging. Microsc Microanal (2011) 1.09
Alterations in cultured myocardial fibroblast function following the development of left ventricular failure. J Mol Cell Cardiol (2006) 1.08
Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts. Antioxid Redox Signal (2013) 1.04
The left ventricle proteome differentiates middle-aged and old left ventricles in mice. J Proteome Res (2008) 1.04
Texas 3-step decellularization protocol: looking at the cardiac extracellular matrix. J Proteomics (2013) 1.01
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res Cardiol (2014) 1.01
Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair (2013) 0.99
Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch (2014) 0.98
Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2013) 0.97
Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. Circulation (2015) 0.96
In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics. J Proteome Res (2010) 0.95
Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond. Cardiovasc Ther (2008) 0.94
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One (2012) 0.94
SPARC mediates early extracellular matrix remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 0.90
Mathematical modeling and stability analysis of macrophage activation in left ventricular remodeling post-myocardial infarction. BMC Genomics (2012) 0.89
Getting to the heart of the matter: age-related changes in diastolic heart function in the longest-lived rodent, the naked mole rat. J Gerontol A Biol Sci Med Sci (2012) 0.89
Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling. BMC Syst Biol (2011) 0.88
Walking the oxidative stress tightrope: a perspective from the naked mole-rat, the longest-living rodent. Curr Pharm Des (2011) 0.88
Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle. Antioxid Redox Signal (2014) 0.88
The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet. Oxid Med Cell Longev (2010) 0.87
Heart failure with preserved ejection fraction: emerging drug strategies. J Cardiovasc Pharmacol (2013) 0.87
Effects of surface-modified scaffolds on the growth and differentiation of mouse adipose-derived stromal cells. J Tissue Eng Regen Med (2007) 0.86
Cardiac extracellular proteome profiling and membrane topology analysis using glycoproteomics. Proteomics Clin Appl (2014) 0.86
Mathematical modeling of left ventricular dimensional changes in mice during aging. BMC Syst Biol (2012) 0.85
Applications of miRNA technology for atherosclerosis. Curr Atheroscler Rep (2014) 0.84
Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates. Circ Res (2014) 0.84
Alterations of pulse pressure stimulate arterial wall matrix remodeling. J Biomech Eng (2009) 0.84
Proteomic analysis reveals late exercise effects on cardiac remodeling following myocardial infarction. J Proteomics (2010) 0.84
Conjugated linoleic acid (CLA) prevents age-associated skeletal muscle loss. Biochem Biophys Res Commun (2009) 0.84
Matrix metalloproteinases: drug targets for myocardial infarction. Curr Drug Targets (2013) 0.84
Alterations in Pulse Pressure Affect Artery Function. Cell Mol Bioeng (2012) 0.84
Using proteomics to uncover extracellular matrix interactions during cardiac remodeling. Proteomics Clin Appl (2013) 0.83
Cardiac wound healing post-myocardial infarction: a novel method to target extracellular matrix remodeling in the left ventricle. Methods Mol Biol (2013) 0.83
Artery buckling stimulates cell proliferation and NF-κB signaling. Am J Physiol Heart Circ Physiol (2014) 0.83
Bayesian parameter estimation for nonlinear modelling of biological pathways. BMC Syst Biol (2011) 0.82
t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity. J Cell Physiol (2011) 0.82
Cardiac function of the naked mole-rat: ecophysiological responses to working underground. Am J Physiol Heart Circ Physiol (2013) 0.82
ACE inhibitors to block MMP-9 activity: new functions for old inhibitors. J Mol Cell Cardiol (2007) 0.82
Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal. Cardiovasc Res (2011) 0.81
Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors? Recent Pat Anticancer Drug Discov (2007) 0.81
DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity. Expert Opin Drug Discov (2012) 0.81
A conceptual cellular interaction model of left ventricular remodelling post-MI: dynamic network with exit-entry competition strategy. BMC Syst Biol (2010) 0.80
Using systems biology approaches to understand cardiac inflammation and extracellular matrix remodeling in the setting of myocardial infarction. Wiley Interdiscip Rev Syst Biol Med (2014) 0.80
Chronic and intermittent hypoxia differentially regulate left ventricular inflammatory and extracellular matrix responses. Hypertens Res (2012) 0.80
Plasma fractionation enriches post-myocardial infarction samples prior to proteomics analysis. Int J Proteomics (2012) 0.80
Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail (2005) 0.80
Left ventricular remodeling: one small step for the extracellular matrix will translate to a giant leap for the myocardium. Congest Heart Fail (2013) 0.80
Understanding the role of the extracellular matrix in cardiovascular development and disease: where do we go from here? J Mol Cell Cardiol (2009) 0.80
Estrogen effects on MMP-13 and MMP-14 regulation of left ventricular mass in Dahl salt-induced hypertension. Gend Med (2008) 0.80
A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities. J Clin Hypertens (Greenwich) (2013) 0.79
Obese and diabetic KKAy mice show increased mortality but improved cardiac function following myocardial infarction. Cardiovasc Pathol (2013) 0.79
HDL-cholesterol levels and cardiovascular risk: acCETPing the context. Eur Heart J (2008) 0.78
Thrombospondin-1: the good, the bad, and the complicated. Circ Res (2013) 0.78
Cardiac assessment in pediatric mice: strain analysis as a diagnostic measurement. Echocardiography (2013) 0.78
Is isolated systolic hypertension worse than combined systolic/diastolic hypertension? J Clin Hypertens (Greenwich) (2012) 0.78
Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates. Methods Mol Biol (2013) 0.78
Fish oil decreases inflammation and reduces cardiac remodeling in rosiglitazone treated aging mice. Pharmacol Res (2010) 0.78
Titin phosphorylation: myocardial passive stiffness regulated by the intracellular giant. Circ Res (2009) 0.78
Heart rate reduction: an old and novel candidate heart failure therapy. Hypertension (2012) 0.77
Crosstalk between cytotoxic T-lymphocyte associated antigen-4 and interleukin-12 in cytotoxic T-lymphocyte-mediated myocarditis: adding another link to the chain. Circ Res (2007) 0.77
Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses. BMC Genomics (2015) 0.76
Extracellular matrix proteomics in cardiac ischemia/reperfusion: the search is on. Circulation (2012) 0.76
Aging modifies the cardiac response to estrogen: a new dimension to hormone replacement therapy. Hypertension (2006) 0.75
Tumor necrosis factor-alpha--converting enzyme roles in hypertension-induced hypertrophy: look both ways when crossing the street. Hypertension (2009) 0.75
Going out on a LIM and cysteine-rich domains 1 limb: a new way to block calcineurin activity. Hypertension (2009) 0.75
AMP activated protein kinase 2 protection during hypertension-induced hypertrophy: a common mediator in the signaling crossroads. Hypertension (2008) 0.75
Heavy hitting: Using water to label humans. Proteomics Clin Appl (2014) 0.75
Tipping the extracellular matrix balance during heart failure progression: do we always go right? Cardiology (2010) 0.75
Beta-blockade in heart failure: adding SENIORS to the mix. Eur Heart J (2006) 0.75
Women are different: the role of coupling factor 6 in blood pressure regulation. Hypertens Res (2012) 0.75
Clinical and Translational Proteomics Focused on Tissue Damage, Repair, and Regeneration. Proteomics Clin Appl (2016) 0.75
Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness. J Cardiovasc Med (Hagerstown) (2017) 0.75